216 related articles for article (PubMed ID: 20428049)
1. GLUT1 and GLUT3 as potential prognostic markers for Oral Squamous Cell Carcinoma.
Ayala FR; Rocha RM; Carvalho KC; Carvalho AL; da Cunha IW; Lourenço SV; Soares FA
Molecules; 2010 Apr; 15(4):2374-87. PubMed ID: 20428049
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Evaluation of GLUT-3 and GLUT-4 in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Feitosa SG; Viana KF; Luna ECM; Costa FWG; Cavalcante RB; Chaves FN; Chaves HV; Pereira KMA
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1779-1783. PubMed ID: 30049187
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical Evaluation of Glucose Transporter Type 1 in Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Pereira KM; Feitosa SG; Lima AT; Luna EC; Cavalcante RB; de Lima KC; Chaves FN; Costa FW
Asian Pac J Cancer Prev; 2016; 17(1):147-51. PubMed ID: 26838200
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of hypoxia-inducible factor-1α and glucose transporter-1 is associated with poor prognosis in oral squamous cell carcinoma patients.
Eckert AW; Lautner MH; Schütze A; Taubert H; Schubert J; Bilkenroth U
Histopathology; 2011 Jun; 58(7):1136-47. PubMed ID: 21438910
[TBL] [Abstract][Full Text] [Related]
5. Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study.
Tian M; Zhang H; Nakasone Y; Mogi K; Endo K
Eur J Nucl Med Mol Imaging; 2004 Jan; 31(1):5-12. PubMed ID: 14551748
[TBL] [Abstract][Full Text] [Related]
6. GLUT-1(+)/TKTL1(+) coexpression predicts poor outcome in oral squamous cell carcinoma.
Grimm M; Munz A; Teriete P; Nadtotschi T; Reinert S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):743-53. PubMed ID: 24703406
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma.
Kunkel M; Reichert TE; Benz P; Lehr HA; Jeong JH; Wieand S; Bartenstein P; Wagner W; Whiteside TL
Cancer; 2003 Feb; 97(4):1015-24. PubMed ID: 12569601
[TBL] [Abstract][Full Text] [Related]
8. Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study.
Gholami S; Chamorro-Petronacci C; Pérez-Sayáns M; Suárez Peñaranda J; Longatto-Filho A; Baltazar F; Afonso J
J Appl Oral Sci; 2023; 31():e20220461. PubMed ID: 37194791
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.
Jonathan RA; Wijffels KI; Peeters W; de Wilde PC; Marres HA; Merkx MA; Oosterwijk E; van der Kogel AJ; Kaanders JH
Radiother Oncol; 2006 Jun; 79(3):288-97. PubMed ID: 16730088
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of GLUT-1 expression in oral squamous cell carcinoma: A prisma-compliant meta-analysis.
Li CX; Sun JL; Gong ZC; Lin ZQ; Liu H
Medicine (Baltimore); 2016 Nov; 95(45):e5324. PubMed ID: 27828852
[TBL] [Abstract][Full Text] [Related]
11. Expression of Glut-1 is a prognostic marker for oral squamous cell carcinoma patients.
Eckert AW; Lautner MH; Taubert H; Schubert J; Bilkenroth U
Oncol Rep; 2008 Dec; 20(6):1381-5. PubMed ID: 19020718
[TBL] [Abstract][Full Text] [Related]
12. [Expression of glucose transporter in non-small cell lung carcinoma and its clinical significance].
Lu GH; Zhong XJ; Ding W; Zhou JY
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 37(2):176-81. PubMed ID: 18422279
[TBL] [Abstract][Full Text] [Related]
13. Co-expression of CD147 and GLUT-1 indicates radiation resistance and poor prognosis in cervical squamous cell carcinoma.
Huang XQ; Chen X; Xie XX; Zhou Q; Li K; Li S; Shen LF; Su J
Int J Clin Exp Pathol; 2014; 7(4):1651-66. PubMed ID: 24817962
[TBL] [Abstract][Full Text] [Related]
14. MiR-200c inhibited the proliferation of oral squamous cell carcinoma cells by targeting Akt pathway and its downstream Glut1.
Yan Y; Yan F; Huang Q
Arch Oral Biol; 2018 Dec; 96():52-57. PubMed ID: 30179745
[TBL] [Abstract][Full Text] [Related]
15. Glucose transporters 1, 3, 6, and 10 are expressed in gastric cancer and glucose transporter 3 is associated with UICC stage and survival.
Schlößer HA; Drebber U; Urbanski A; Haase S; Baltin C; Berlth F; Neiß S; von Bergwelt-Baildon M; Fetzner UK; Warnecke-Eberz U; Bollschweiler E; Hölscher AH; Mönig SP; Alakus H
Gastric Cancer; 2017 Jan; 20(1):83-91. PubMed ID: 26643879
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of GLUT-1 is associated with resistance to radiotherapy and adverse prognosis in squamous cell carcinoma of the oral cavity.
Kunkel M; Moergel M; Stockinger M; Jeong JH; Fritz G; Lehr HA; Whiteside TL
Oral Oncol; 2007 Sep; 43(8):796-803. PubMed ID: 17207657
[TBL] [Abstract][Full Text] [Related]
17. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation of glucose transporters in human oral squamous cell carcinoma cells.
Paolini R; Moore C; Matthyssen T; Cirillo N; McCullough M; Farah CS; Botha H; Yap T; Celentano A
J Oral Pathol Med; 2022 Sep; 51(8):679-683. PubMed ID: 35920070
[TBL] [Abstract][Full Text] [Related]
19. Caveolin-1 Expression at Metastatic Lymph Nodes Predicts Unfavorable Outcome in Patients with Oral Squamous Cell Carcinoma.
Kato K; Miyazawa H; Kobayashi H; Noguchi N; Lambert D; Kawashiri S
Pathol Oncol Res; 2020 Oct; 26(4):2105-2113. PubMed ID: 31907776
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of carbonic anhydrase 9, glucose transporter-1, Ki-67 and p53 expression in oral squamous cell carcinoma.
Kondo Y; Yoshikawa K; Omura Y; Shinohara A; Kazaoka Y; Sano J; Mizuno Y; Yokoi T; Yamada S
Oncol Rep; 2011 May; 25(5):1227-33. PubMed ID: 21399882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
